Neuphoria Therapeutics In...

NASDAQ: NEUP · Real-Time Price · USD
6.80
-0.14 (-2.02%)
At close: Aug 21, 2025, 3:59 PM
6.92
1.76%
After-hours: Aug 21, 2025, 06:43 PM EDT

Neuphoria Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is July - June.
Fiscal Year Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020
Net Income
5.83M -5.44M -8.05M -12.71M -10.03M -10.03M -5.47M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Depreciation & Amortization
662.95K 497.52K 497.09K 497.29K 331.6K 331.6K 165.91K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
173.22K 153.54K 691.43K 797.43K 689.72K 689.72K 132.74K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Working Capital
-158.48K -540.87K 407.04K 350.62K -264.15K -13.61K -348.28K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Non-Cash Items
-6.1M -8.94M -7.56M -4.72M -1.86M -5.01M -9.12M -11.46M -11.46M -8.86M -10.37M -12.04M -15.24M -14.27M -7.81M -6.14M -4.64M -4.14M -3.7M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
87.39K -376.82K -261.16K 1.45M -802.99K 303.74K 516.08K n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Cash Flow
651.66K -14.1M -14.68M -14.68M -11.67M -13.71M -13.78M -11.46M -11.46M -8.86M -10.37M -12.04M -15.24M -14.27M -7.81M -6.14M -4.64M -4.14M -3.7M
Capital Expenditures
3.00 3.00 3.00 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -89.41K -89.41K -88.64K -88.64K 768.86 768.86 n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a 187.41K 187.41K 317.41K 317.41K 100.99K 99.49K 289.23K 414.81K 432.55K 434.05K 126.61K 24.6K 17.32K -420.57K -403.47K
Investing Cash Flow
n/a n/a n/a n/a 187.41K 187.41K 317.41K 317.41K 100.99K 99.49K 289.23K 414.81K 343.14K 344.64K 37.97K -64.04K 18.09K -419.8K -403.47K
Debt Repayment
n/a n/a n/a n/a -25.28K -52.14K -80.55K -105.94K -80.66K -53.8K -52.59K -71.7K -6.13M -7.48M -8.41M -8.37M -2.83M -2.73M -3.2M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
5.03M 4.96M 10.3M 4.65M -491.89K -631.81K -6.91M -1.26M -1.23M -1.3M -2.41M -3.25M -3.26M -3.04M -1.13M -314.97K -203.02K -174.11K -25.72K
Financial Cash Flow
7.95M 8.54M 14.27M 15.11M 7.82M 5.87M 4.32M 3.68M 1.7M 4.83M 19.43M 18.59M 30.2M 40.12M 21.68M 24.36M 16.62M 2.53M 862.21K
Net Cash Flow
8.62M -5.82M -46.97K 504.99K -6.67M -10.48M -12.08M -9.5M -13.1M -8.13M 4.78M 1.63M 14.35M 26.04M 13.84M 18.15M 11.97M -2.06M -3.18M
Free Cash Flow
417.17K -14.1M -14.68M -14.68M -14.34M -16.37M -16.45M -14.13M -14.7M -12.1M -13.61M -15.28M -15.24M -14.27M -7.81M -6.14M -4.64M -4.14M -3.7M